All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Issuers›Global X›AGNG
AGNG

Global X Aging Population ETF

The AGNG Exchange Traded Fund (ETF) is provided by Global X. It is built to track an index: Indxx Aging Population Thematic Index. The AGNG ETF provides physical exposure, so by buying it you actually own parts of all the 84 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$36.71
-$0.12 (-0.33%) yesterday
1:30 PM 07/17/26 Closed
1D price range
$36.68$37.03
52W price range
$31.86$38.32
YTD Perf.
+3.24%
YTD Flows
Annualized volatility
Fund AuM
€76M
Share class AuM
€76M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US37954Y7720
TER
0.5%
Inception date
5/9/2016
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 16, 2026
-6%-4%-2%0%2%4%6%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
90.59%
Finance
8.83%
Unavailable
0.26%
Other
0.32%
Latest AGNG news

No content available for this fund

FAQ about AGNG

AGNG is a Passive ETF. This ETF provides exposure to Developed markets Equities.
AGNG tracks the Indxx Aging Population Thematic Index - USD, through a full replication replication method.
AGNG carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.
AGNG was introduced to the market on May 9, 2016. It trades on United States
Global X Aging Population ETF, AGNG, is provided by Global X. Learn more about Global X here.
AGNG oversees €76M in assets as of July 16, 2026.
AGNG follows a distributing dividend policy, meaning it pays out income to investors. As of July 16, 2026, its 12-month trailing yield was 0.89%.
As of May 31, 2026, AGNG has significant geographic allocations in USA, Switzerland and Japan.
As of May 31, 2026, AGNG focuses largely on Healthcare and Finance.
As of May 31, 2026, AGNG holds 84 positions in its portfolio, with 46.25% of assets concentrated in its top 15 holdings.
As of May 31, 2026, AGNG top three holdings include Novo Nordisk A/S, Eli Lilly & Co. and Edwards Lifesciences Corp..
The base currency of AGNG is USD.
Data as of 05/31/26
Novo Nordisk A/S
3.80%
Eli Lilly & Co.
3.58%
Edwards Lifesciences Corp.
3.37%
Roche Holding AG
3.21%
AbbVie, Inc.
3.16%
Welltower, Inc.
3.07%
Ventas, Inc.
3.06%
Merck & Co., Inc.
2.99%
Bristol Myers Squibb Co.
2.98%
Amgen, Inc.
2.93%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight